LEP and neoplasm: In colorectal cancer macrophage-specific metabolites, itaconate can exert cancer-promoting effects in M2 macrophages through downregulation of peroxisome proliferator-activated receptor gamma (PPARΥ), a cellular pathway that is regulated by leptin and acts as a tumor-suppressing factor.